|
|
|
|
| LEADER |
00000cam a2200000 c 4500 |
| 001 |
1777400430 |
| 003 |
DE-627 |
| 005 |
20240510210644.0 |
| 007 |
tu |
| 008 |
211115s2020 gw ||||| m 00| ||eng c |
| 035 |
|
|
|a (DE-627)1777400430
|
| 035 |
|
|
|a (DE-599)KXP1777400430
|
| 035 |
|
|
|a (OCoLC)1285269623
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XA-DE-BW
|
| 084 |
|
|
|a 33
|2 sdnb
|
| 100 |
1 |
|
|a Yoo, Hyeon Joo
|e VerfasserIn
|0 (DE-588)1196908664
|0 (DE-627)1678777552
|4 aut
|
| 245 |
1 |
0 |
|a Tumor-specific reactive oxygen species accelerators for improved chimeric antigen receptor (CAR) T cell therapy in B cell malignancies
|c vorgelegt von Hyeon Joo Yoo ; Doktorvater: Prof. Dr. med. Michael Schmitt
|
| 264 |
|
1 |
|a Heidelberg
|c 2020
|
| 300 |
|
|
|a IV, 85 Blätter
|b Illustrationen, Diagramme
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 502 |
|
|
|b Dissertation
|c Ruprecht-Karls-Universität Heidelberg
|d 2021
|
| 583 |
1 |
|
|a Archivierung/Langzeitarchivierung gewährleistet
|f DISS
|x XA-DE-BW
|2 pdager
|5 DE-16
|
| 655 |
|
7 |
|a Hochschulschrift
|0 (DE-588)4113937-9
|0 (DE-627)105825778
|0 (DE-576)209480580
|2 gnd-content
|
| 700 |
1 |
|
|a Schmitt, Michael
|d 1966-
|e AkademischeR BetreuerIn
|0 (DE-588)133177173
|0 (DE-627)538000600
|0 (DE-576)299672921
|4 dgs
|
| 710 |
2 |
|
|a Universität Heidelberg
|e Grad-verleihende Institution
|0 (DE-588)2024349-2
|0 (DE-627)102161488
|0 (DE-576)191769517
|4 dgg
|
| 751 |
|
|
|a Heidelberg
|0 (DE-588)4023996-2
|0 (DE-627)106300814
|0 (DE-576)208952578
|4 uvp
|
| 951 |
|
|
|a BO
|
| 992 |
|
|
|a 20211118
|
| 993 |
|
|
|a Thesis
|
| 994 |
|
|
|a 2021
|
| 998 |
|
|
|g 1196908664
|a Yoo, Hyeon Joo
|m 1196908664:Yoo, Hyeon Joo
|d 50000
|d 51001
|e 50000PY1196908664
|e 51001PY1196908664
|k 0/50000/
|k 1/50000/51001/
|p 1
|x j
|y j
|
| 999 |
|
|
|a KXP-PPN1777400430
|e 4003304071
|
| BIB |
|
|
|a Y
|
| JSO |
|
|
|a {"origin":[{"dateIssuedDisp":"2020","dateIssuedKey":"2020","publisherPlace":"Heidelberg"}],"id":{"eki":["1777400430"]},"recId":"1777400430","name":{"displayForm":["vorgelegt von Hyeon Joo Yoo ; Doktorvater: Prof. Dr. med. Michael Schmitt"]},"title":[{"title_sort":"Tumor-specific reactive oxygen species accelerators for improved chimeric antigen receptor (CAR) T cell therapy in B cell malignancies","title":"Tumor-specific reactive oxygen species accelerators for improved chimeric antigen receptor (CAR) T cell therapy in B cell malignancies"}],"person":[{"family":"Yoo","role":"aut","given":"Hyeon Joo","display":"Yoo, Hyeon Joo"},{"display":"Schmitt, Michael","role":"dgs","given":"Michael","family":"Schmitt"}],"corporate":[{"display":"Universität Heidelberg","role":"dgg"}],"type":{"bibl":"thesis"},"physDesc":[{"extent":"IV, 85 Blätter","noteIll":"Illustrationen, Diagramme"}],"language":["eng"],"noteThesis":["Dissertation. - Ruprecht-Karls-Universität Heidelberg. - 2021"]}
|
| SRT |
|
|
|a YOOHYEONJOTUMORSPECI2020
|
